Company: SERV
Filing Date: 2025-01-07
Form Type: 424B3
Source: 0001213900-25-001710
Chunk: 0

Company: Serve Robotics Inc. /DE/
Filing Date: 2025-01-07
Form: 424B3
Chunk 0
---
Filed Pursuant to Rule 424(b)(3)
Registration No. 333-281113

PROSPECTUS SUPPLEMENT NO. 4

(to Prospectus dated August 6, 2024)

<div align='center'>Serve Robotics Inc.

5,000,000 Shares of Common Stock</div>

This prospectus supplement supplements the prospectus dated August 6, 2024 (the “Prospectus”), which forms a part of our registration statement on Form S-1 (No. 333-281113). This prospectus supplement is being filed to update and supplement the information in the Prospectus with the information contained in our Current Reports on Form 8-K, filed with the SEC on December 9, 2024, January 6, 2025 and January 7, 2025 (the “Current Reports”). Accordingly, we have attached the Current Reports to this prospectus supplement.

The Prospectus and this prospectus supplement relate
to the offer and sale from time to time by the selling stockholders named in the Prospectus (the “Selling Stockholders”) of
up to 5,000,000 shares of our Common Stock, $0.0001 par value per share (“Common Stock”), which includes: (i) 2,500,000 shares
of our Common Stock issuable upon exercise of the pre-funded warrants issued to Armistice Capital Master Fund Ltd. (“Armistice”)
in connection with a private placement of warrants and pre-funded warrants (the “July 2024 PIPE”) and (ii) 2,500,000 shares
of our Common Stock issuable upon exercise of the warrants issued to Armistice in connection with the July 2024 PIPE.

Our Common Stock is quoted on The Nasdaq Capital
Market under the symbol “SERV”. On January 6, 2025, the closing price of our Common Stock on The Nasdaq Capital Market was
$22.89 per share.

This prospectus supplement updates and supplements
the information in the Prospectus and is not complete without, and may not be delivered or utilized except in combination with, the Prospectus,
including any amendments or supplements thereto. This prospectus supplement should be read in conjunction with the Prospectus and if there
is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the information in this
prospectus supplement.

See the section entitled “ Risk Factors” beginning on page 7 of the